| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 58.710 | 60.517 | 67.943 | 43.268 | 172.143 | 191.430 | 114.913 | 12.087 | 0 | 0 |
| Total Income - EUR | 59.893 | 61.066 | 67.947 | 43.376 | 172.318 | 191.439 | 114.884 | 16.304 | 0 | 1.317 |
| Total Expenses - EUR | 56.374 | 63.076 | 58.400 | 39.457 | 167.172 | 186.195 | 124.358 | 27.967 | 1.588 | 1.317 |
| Gross Profit/Loss - EUR | 3.519 | -2.010 | 9.547 | 3.919 | 5.146 | 5.244 | -9.474 | -11.663 | -1.588 | 0 |
| Net Profit/Loss - EUR | 1.722 | -3.236 | 4.575 | 3.485 | 3.570 | 3.394 | -10.557 | -12.152 | -1.588 | 0 |
| Employees | 2 | 2 | 2 | 3 | 10 | 10 | 9 | 2 | 0 | 0 |
Check the financial reports for the company - Mike Pharm Trade S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 186.415 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 22.508 | 21.513 | 18.856 | 18.313 | 75.719 | 102.095 | 100.540 | 29.931 | 12.643 | 8.967 |
| Inventories | 10.124 | 16.623 | 2.147 | 13.925 | 34.346 | 46.673 | 40.449 | 23.214 | 677 | 0 |
| Receivables | 10.827 | 2.221 | 15.929 | 4.147 | 36.268 | 49.822 | 52.732 | 0 | 11.933 | 8.787 |
| Cash | 1.557 | 2.669 | 780 | 241 | 5.106 | 5.600 | 7.359 | 6.718 | 33 | 181 |
| Shareholders Funds | 1.330 | -1.874 | 2.732 | 6.167 | 9.618 | 12.829 | 1.988 | 6.263 | -18.406 | -18.303 |
| Social Capital | 45 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 21.178 | 23.387 | 202.538 | 12.145 | 66.101 | 89.266 | 98.552 | 23.668 | 31.049 | 27.271 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Mike Pharm Trade S.r.l.